Reactions of oxidized LDL on cells of acute myeloid leukemia

Leukemia Research

Volumn 21, Issue 11-12, 1997, Pages 1071-1076

  Vahrenwald, Frank ^a   Galka, Kay ^a   Jürgens, Günther ^b   Bruchelt, Gernot ^a   Girgert, Rainer ^a   Schweizer, Paul ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Acute myeloid leukemia; Drug targeting; Oxidized low density lipoprotein; Purging

Indexed keywords

ALDEHYDE; COPPER SULFATE; DRUG VEHICLE; LIPID PEROXIDE; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; EDETIC ACID; LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL KILLING; CONTROLLED STUDY; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; ACUTE MONOCYTIC LEUKEMIA; BLOOD; CELL CULTURE; CHEMISTRY; ELECTROPHORESIS; HYPERLIPOPROTEINEMIA TYPE 2; KINETICS; OXIDATION REDUCTION REACTION; PROMYELOCYTIC LEUKEMIA;

COPPER SULFATE; EDETIC ACID; ELECTROPHORESIS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; KINETICS; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; LIPID PEROXIDES; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR CELLS, CULTURED;

EID: 0031262737     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00097-0     Document Type: Article

References (27)

1. Volm, M. D. and Tallman, M. S., Developments in the treatment of acute leukemia in adults. Curr. Opin. Oncol., 1995, 7, 28.
2. Snyder, D. S., Chao, N. J., Amylon, M. D., Taguchi, J., Long, G. D., Negrin, R. S., Nademanee, A. P., O'Donnell, M. R., Schmidt, G. M., Stein, A. S., Parker, P. M., Smith, E. P., Stepan, D. E., Molina, A., Lipsett, J. A., Hoppe, R. T., Niland, J. C., Dagis, A. C., Wong, R. M., Forman, S. J. and Blume, K. G., Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood, 1993, 82, 2920.
3. Selvaggi, K. J., Wilson, J. W., Mills, L. E., Cornwell, G. G. III, Hurd, D., Dodge, W., Gingrich, R., Martin, S. E., McMillan, R., Miller, W. and Ball, E. D., Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow. Blood, 1994, 83, 1698.
4. McGraw, K. J., Rosenblum, M. G., Cheung, L. and Scheinberg, D. A., Characterization of murine and humanized anti-CD33, gelonin immunotoxins reactive against myeloid leukemias. Cancer Immunol. Immunother., 1994, 39, 367.
5. Kreitman, R. J., Chaudhary, V. K., Waldmann, T. A., Hanchard, B., Cranston, B., FitzGerald, D. J. and Pastan, I., Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia. Leukemia, 1993, 7, 553.
6. Faulk, W. P., Taylor, C. G., Yeh, C. J. and McIntyre, J. A., Preliminary clinical study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients. Mol. Biother., 1990, 2, 57.
7. Vitols, S., Gahrton, G., Bjorkholm, M. and Peterson, C., Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia. Lancet, 1985, 2, 1150.
8. Ho, Y. K., Smith, R. G., Brown, M. S. and Goldstein, J. L., Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood, 1978, 52, 1099.
9. Vitols, S., Gahrton, G. and Peterson, C., Significance of the low-density lipoprotein (LDL) receptor pathway for the in vitro accumulation of AD-32 incorporated into LDL in normal and leukemic white blood cells. Cancer Treat. Rep., 1984, 68, 515.
10. Samadi-Baboli, M., Favre, G., Canal, P. and Soula, G., Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice. Br. J. Cancer, 1993, 68, 319.
11. Esterbauer, H., Jürgens, G., Quehenberger, O. and Koller, E., Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res., 1987, 28, 495.
12. Jürgens, G., Hoff, H. F., Chisolm, G. M. and Esterbauer, H., Modification of human serum low density lipoprotein by oxidation. Characterization and pathophysiological implications. Chem. Phys. Lipids, 1987, 45, 315.
13. Knisel, W., Müller, M., Besenthal, I., di-Nicuolo, A., Rebstock, M., Risler, T. and Eggstein, M., Application of a new LDL apheresis system using two dextran sulfate cellulose columns in combination with an automatic column-regenerating unit and a blood cell separator. J. Clin. Apheresis, 1991, 6, 11.
14. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J., Quantitative measurement of proteins. J. Biol. Chem., 1951, 193, 265.
15. El-Saadani, M., Esterbauer, H., El-Sayed, M., Goher, M., Nassar, A. Y. and Jürgens, G., A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res., 1989, 30, 627.
16. Slater, T. F. and Sawyer, B. C., The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used. Biochem J., 1971, 123, 805.
17. Lenz, M., Miehe, W-P., Vahrenwald, F., Bruchelt, G., Schweizer, P. and Girgert, R., Cholesterol based antineoplastic strategies. Anticancer Res., 1997, 17, 1143.
18. Mossmann, T., Rapid colorimetric assay for cellular growth and survival. Application to proliferative and cytotoxicity assays. J. Immunol. Meth., 1983, 65, 55.
19. Jessup, W., Jürgens, G., Lang, J., Esterbauer, H. and Dean, R. T., Interaction of 4-hydroxynonenal-modified low-density lipoproteins with the fibroblast apolipoprotein B/E receptor. Biochem J., 1986, 234, 245.
20. Chisolm, G. M., Ma, G., Irwin, K. C., Martin, L. L., Gunderson, K. G., Linberg, L. F., Morel, D. W. and DiCorleto, P. E., 7β-hydroperoxycholest-5-en-3β-ol, a component of human artheriosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci., 1994, 91, 11452.
21. Kodama, T., Doi, T., Suzuki, H., Takahashi, K., Wada, Y. and Gordon, S., Collagenous macrophage scavenger receptors. Curr. Opin. Lipidol., 1996, 7, 287.
22. Janssen, J. W. G., Steenvoorden, A. C., Lyons, J., Anger, B., Bohlke, J. U., Bos, J. L., Seliger, H. and Bartram, C. R., RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc. Natl. Acad. Sci., 1987, 84, 9228.
23. Banka, C. L., Black, A. S., Dyer, C. A. and Curtiss, L. K., THP-1 cells form foam cells in response to coculture with lipoproteins but not platelets. J. Lipid. Res., 1991, 32, 35.
24. Vitols, S., Soderberg-Reid, K., Masquelier, M., Sjostrom, B. and Peterson, C., Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex. Br. J. Cancer, 1990, 62, 724.
25. Carew, T. E., Pittman, R. C. and Steinberg, D., Tissue sites of degradation of native and reductively methylated [14C] sucrose-labelled low density lipoprotein in rats. Contribution of receptor-dependent and receptor-independent pathways. J. Biol. Chem., 1982, 257, 8001.
26. Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T. and Protter, A. A., CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem., 1994, 268, 11811.
27. Oertel, J., Oertel, B., Schleicher, J. and Huhn, D., Immunotyping of blasts in human bone marrow. Ann. Hematol., 1996, 72, 125.